New Delhi: Swedish personal fairness agency EQT has emerged because the sole contender to amass Sanjaya Mariwala-promoted OmniActive Health Technologies, after the one competing bid for the nutraceuticals producer and exporter was not too long ago rejected, individuals conscious of the matter mentioned.
EQT was competing with a consortium of Temasek and Novo Holdings for a controlling stake within the firm, they informed ET, including that EQT’s provide was higher.
Sanjaya Mariwala is the founding father of OmniActive Health Technologies, however it’s managed by US personal fairness agency TA Associates, after the latter purchased a 56% stake within the firm in 2021. The Temasek and Novo Holdings consortium’s provide gave OmniActive Health Technologies a valuation of between ₹5,500 crore and ₹5,800 crore, the individuals cited earlier mentioned.
EQT and TA Associates’ managing director and co-head of Asia, Dhiraj Poddar, declined to remark.
Mariwala didn’t reply to ETs question. Temasek and Novo Holdings didn’t touch upon the matter.
“Talks will proceed with EQT although there may be additionally a risk that TA Associates abandons the discussions and restarts a recent stake sale course of later within the 12 months,” an individual aware of the event mentioned, requesting to not be named.
Mariwala nonetheless holds a major minority stake in OmniActive Health Technologies.
OmniActive Health Technologies has important exports to the US market and potential bidders have valued the corporate conservatively due to that motive, as per sources. Preliminary valuation expectations conveyed to the potential bidders was round $1 billion or ₹9,500 crore.
“Close to-term income progress from the US is anticipated to be reasonable owing to the deferment of latest product launches amid heightened uncertainty surrounding commerce insurance policies,” scores company CRISIL mentioned in a notice on 22 January.
OmniActive Health’s merchandise within the specialty and botanical segments embrace Lutemax 2020, Omnixan, Capsimax, Gingever and enXtra within the therapeutic segments of imaginative and prescient, cognition and psychological well being, metabolic well being and weight administration, energetic wellness and pure power. A few of these merchandise are mentioned to be market leaders of their respective segments.
“Longstanding relationships with clients by way of co-development and co-branding of merchandise give the group an edge available in the market,” CRISIL mentioned within the 22 January notice.
OmniActive Health Technologies has vertically built-in operations for main merchandise, together with direct sourcing of marigold and paprika from farmers.
Its enterprise is uncovered to uncooked materials worth fluctuations within the agriculture sector and seasonality.
The corporate operates by way of numerous arms, together with abroad subsidiaries equivalent to OmniActive Health Technologies Inc. (USA), Omniactive Health Technologies (Canada) Restricted, Omniactive Health Technologies GMBH (Switzerland), and Indian subsidiaries equivalent to Omnikan Earth Sciences Personal Restricted, Omni Wellness and Vitamin Restricted, PAEON Wellness and Vitamin Restricted, and OmniActive Enhancing Lives Basis.
It had income of round Rs 886 crore in 2024-25, for which information is out there.
Source link
#EQT #emerges #sole #bidder #OmniActive #Health #Technologies
